Clinical Trial Update: Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)

View source ↗

Summary

MAP-HEART is an ongoing clinical trial in heart failure, currently enrolling by invitation to study multi-scale phenotypes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Heart Failure | Status: ENROLLING_BY_INVITATION